Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Division of Pulmonary, Allergy, and Critical Care, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Chest. 2021 Feb;159(2):e107-e113. doi: 10.1016/j.chest.2020.09.243.
A 53-year-old man presented to the ED at a time of low severe acute respiratory syndrome coronavirus 2, also known as coronavirus disease 2019 (COVID-19), prevalence and reported 2 weeks of progressive shortness of breath, dry cough, headache, myalgias, diarrhea, and recurrent low-grade fevers to 39°C for 1 week with several days of recorded peripheral capillary oxygen saturation of 80% to 90% (room air) on home pulse oximeter. Five days earlier, he had visited an urgent care center where a routine respiratory viral panel was reportedly negative. A COVID-19 reverse transcriptase polymerase chain reaction test result was pending at the time of ED visit. He reported a past medical history of gastroesophageal reflux disease that was treated with famotidine. Travel history included an out-of-state trip 3 weeks earlier, but no recent international travel.
一位 53 岁男性在严重急性呼吸系统综合征冠状病毒 2 型(也称为 2019 年冠状病毒病,COVID-19)流行率较低的时期到急诊就诊,自述出现 2 周进行性呼吸急促、干咳、头痛、肌痛、腹泻和反复低热至 39°C,持续 1 周,数天在家用脉搏血氧仪上记录到外周毛细血管血氧饱和度为 80%至 90%(室内空气)。5 天前,他曾去看急诊,在那里报告常规呼吸道病毒检测结果为阴性。在就诊时,COVID-19 逆转录酶聚合酶链反应检测结果尚未出来。他报告有胃食管反流病的既往病史,用法莫替丁治疗。旅行史包括 3 周前的州外旅行,但没有最近的国际旅行。